Literature DB >> 18464351

Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule.

.   

Abstract

This rule finalizes the February 4, 2005 proposed rule entitled "Medicare Program; Conditions for Coverage for End-Stage Renal Disease Facilities." It establishes new conditions for coverage that dialysis facilities must meet to be certified under the Medicare program. This final rule focuses on the patient and the results of care provided to the patient, establishes performance expectations for facilities, encourages patients to participate in their plan of care and treatment, eliminates many procedural requirements from the previous conditions for coverage, preserves strong process measures when necessary to promote meaningful patient safety, well-being, and continuous quality improvement. This final rule reflects the advances in dialysis technology and standard care practices since the requirements were last revised in their entirety in 1976.

Entities:  

Mesh:

Year:  2008        PMID: 18464351

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  45 in total

1.  Training of surgeons in peritoneal dialysis catheter placement in the United States: a national survey.

Authors:  Leslie P Wong; Scott E Liebman; Katherine A Wakefield; Susan Messing
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

2.  Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach.

Authors:  Amy Barton Pai; Katie E Cardone; Harold J Manley; Wendy L St Peter; Rachel Shaffer; Michael Somers; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

Review 3.  Role of telehealth in renal replacement therapy education.

Authors:  Anna Malkina; Delphine S Tuot
Journal:  Semin Dial       Date:  2018-01-03       Impact factor: 3.455

4.  Direct Delivery of Kidney Transplant Education to Black and Low-Income Patients Receiving Dialysis: A Randomized Controlled Trial.

Authors:  Amy D Waterman; John Devin Peipert; Anna-Michelle McSorley; Christina J Goalby; Jennifer L Beaumont; Leanne Peace
Journal:  Am J Kidney Dis       Date:  2019-06-19       Impact factor: 8.860

Review 5.  The medical director in integrated clinical care models.

Authors:  Thomas F Parker; George R Aronoff
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-28       Impact factor: 8.237

6.  Introduction: Role of the medical director series.

Authors:  Robert Provenzano; Jeffrey L Hymes
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-12       Impact factor: 8.237

7.  Integrating Quality Improvement Education into the Nephrology Curricular Milestones Framework and the Clinical Learning Environment Review.

Authors:  Lisa K Prince; Dustin J Little; Katherine I Schexneider; Christina M Yuan
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

8.  The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients.

Authors:  Eric P Sorensen; Mark J Sarnak; Hocine Tighiouart; Tammy Scott; Lena M Giang; Bethany Kirkpatrick; Kristina Lou; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2012-03-15       Impact factor: 8.860

9.  Legal Issues for the Medical Director.

Authors:  William G Trulove
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-09       Impact factor: 8.237

10.  Presentation and Outcomes of Patients with ESKD and COVID-19.

Authors:  Anthony M Valeri; Shelief Y Robbins-Juarez; Jacob S Stevens; Wooin Ahn; Maya K Rao; Jai Radhakrishnan; Ali G Gharavi; Sumit Mohan; S Ali Husain
Journal:  J Am Soc Nephrol       Date:  2020-05-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.